Literature DB >> 16120959

Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia.

P Marc van der Zee1, Hein J Verberne, Jan P van Straalen, Gerard T B Sanders, Berthe L F Van Eck-Smit, Robbert J de Winter, Johan C Fischer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120959     DOI: 10.1373/clinchem.2005.054635

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?

Authors:  Aysel Kiyici; Idris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçin Solak; Süleyman Türk
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers.

Authors:  Theodore Pipikos; Alkistis Kapelouzou; Diamantis I Tsilimigras; Yannis Fostinis; Marina Pipikou; Athanassios Theodorakos; Antonis N Pavlidis; Christos Kontogiannis; Dennis V Cokkinos; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

3.  Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.

Authors:  Hamit Yasar Ellidag; Esin Eren; Necat Yılmaz; Yesim Cekin
Journal:  Redox Rep       Date:  2014-01-13       Impact factor: 4.412

4.  Ischemia-modified albumin: could it be a new oxidative stress biomarker for colorectal carcinoma?

Authors:  Hamit Yasar Ellidag; Nurullah Bulbuller; Esin Eren; Sedat Abusoglu; Evren Akgol; Mustafa Cetiner; Necat Yılmaz
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

5.  Ischemia-modified albumin (IMA) is not useful for detecting myocardial ischemia during symptom-limited exercise stress tests.

Authors:  June Hong Kim; Jae Hoon Choi; Hyun-Kook Lee; Woo Hyung Bae; Kook-Jin Chun; Yun Seong Kim; Sang Kwon Lee; Hyung Hoi Kim; Taek Jong Hong; Yong Woo Shin
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 3.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.